Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-24 @ 10:58 PM
NCT ID:
NCT00200369
Eligibility Criteria:
Inclusion Criteria:
* HIV infection
* Receiving twice daily Kaletra at an FDA approved dosage
* Age\>18 years
* CD4 and viral load available within seven day of enrollment
* Patient willingness to accept MEMS cap monitoring
* HIV genotype within 60 days of enrollment for patients with viral load\>1000
* Patient willingness to grant informed consent and complete five study visits
Exclusion Criteria:
* Provider or patient deem it unlikely that Kaletra therapy will continue for the ensuing 24 weeks
* Prescription of any medication that is contraindicated for Kaletra recipients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT00200369
Study Brief:
Protocol Section:
NCT00200369